Skip to main content

Month: May 2022

NoHo Partners Plc: Managers’ transactions (Suominen)

NoHo Partners Plc MANAGERS’ TRANSACTIONS 13 May 2022 17:39 NoHo Partners Plc: Managers’ transactions (Suominen) The managers’ transaction announcement is related to an arrangement in which NoHo Partners Plc’s management and domestic investors obtained a loan with a right to conversion from Tesi and converted it into new shares of the Company. The Company has announced the subscription of shares on the basis of special rights related to this arrangement in a stock exchange release published today, 13 May 2022. ____________________________________________ Person subject to the notification requirement Name: Jarno Suominen Position: Other senior manager Issuer: NoHo Partners Oyj LEI: 743700DYZ6R1QNLWQA56 Notification type: INITIAL NOTIFICATION Reference number: 14796/10/12 ____________________________________________ Transaction...

Continue reading

NoHo Partners Plc: Managers’ transactions (Suominen)

NoHo Partners Plc MANAGERS’ TRANSACTIONS 13 May 2022 17:39 NoHo Partners Plc: Managers’ transactions (Suominen) The managers’ transaction announcement is related to an arrangement in which NoHo Partners Plc’s management and domestic investors obtained a loan with a right to conversion from Tesi and converted it into new shares of the Company. The Company has announced the subscription of shares on the basis of special rights related to this arrangement in a stock exchange release published today, 13 May 2022.____________________________________________ Person subject to the notification requirement Name: Jarno Suominen Position: Other senior manager Issuer: NoHo Partners Oyj LEI: 743700DYZ6R1QNLWQA56 Notification type: INITIAL NOTIFICATION Reference number: 14799/8/10 ____________________________________________ Transaction...

Continue reading

Subscription for shares in NoHo Partners Plc based on special rights

NoHo Partners Plc STOCK EXCHANGE RELEASE 13 May 2022 at 17:30 Subscription for shares in NoHo Partners Plc based on special rights The board of directors of NoHo Partners Plc has today approved the subscription for shares based on special rights issued by the company. Based on the subscriptions, the company will issue a total of 1,266,300 new shares. The special rights the subscriptions were made with were related to the convertible loan granted to the company by the state-owned investment company Finnish Industry Investment Ltd (Tesi) which the company announced on 29 May 2020 and 29 June 2020. Tesi granted the loan to the company as a part of the financing package to address the exceptional circumstances created by the coronavirus pandemic. Tesi has today transferred most of the loan, and special rights related thereto to investors who...

Continue reading

PGS ASA: Implementation of 2022 Employee Long-term Incentive Plan

May 13, 2022, Oslo, Norway: PGS (or the “Company”) announces that the 2022 long term incentive plan, as approved by the Annual General Meeting on April 27, 2022, has now been implemented by allocating 6 669 000 Performance based Restricted Stock Units (“PRSUs”). The awards are based on amongst other considerations the position in the Company and a review on the individual participant’s performance prior to award. Any PRSU awarded will, subject to the participant’s continued employment with the Company (or a subsidiary), be settled three years after grant. The complete terms and conditions of the award are described in the calling notice for the 2022 Annual General Meeting. Delivery of shares will take place from the Company’s pool of treasury shares or, if an insufficient number of treasury shares...

Continue reading

Interim report for the first quarter 2022

Please find attached the first quarter interim report for 2022 for Bank Norwegian ASA. For further information, see the full reporting material for the quarter at: https://www.banknorwegian.no/OmOss/InvestorRelations   For any questions please contact: CEO and CFO, Klara-Lise Aasen; phone: +47 47635583; e-mail: kaa@banknorwegian.no Head of Treasury, Mats Benserud; phone: +47 95891539; e-mail: mbe@banknorwegian.no   This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading ActAttachmentReport for the first quarter 2022 Bank Norwegian Group

Continue reading

Clearmind Announces Pre-IND Meeting Date with FDA

Clearmind aims to initiate clinical trials with CMND-100 by year’s end Vancouver, May 13, 2022 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (CSE: CMND, OTC Pink: CMNDF, FSE: CWY0) (“Clearmind” or the “Company“), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under treated health problems, today announced that it will meet with the Center for Drug Evaluation and Research (“CDER”) of the U.S. Food and Drug Administration (“FDA”) on Wednesday, May 18, 2022. The meeting is to discuss numerous aspects of Clearmind’s planned First in Human (“FIH”) study evaluating its proprietary drug candidate CMND-100 for the treatment of Alcohol Use Disorder (“AUD”). Clearmind’s CEO, Dr. Adi Zuloff-Shani, commenting on the meeting said “The meeting with the FDA is an important...

Continue reading

OMID Posts First-Quarter 2022 Financial Statements

Phillipsburg, NJ , May 13, 2022 (GLOBE NEWSWIRE) — Today, OMID Holdings, Inc. (OTC Pink: OMID) posted its Unaudited Financial & Disclosure Statements for the Three Months Ended March 31, 2022. During the period, OMID realized record first-quarter revenue; some notable financial highlights are further detailed below. Highlighted Operating Results for the First Quarter of 2022Revenue for 1Q2022 was $358,772 compared to $278,124 for 1Q2021, a 29% improvement from the comparative quarter in the previous year. Gross Profit for 1Q2022 was $175,247 compared to $139,126 for 1Q2021, a 26% improvement from the comparative quarter in the previous year. Net Income before income taxes for 1Q2022 was $75,209 compared to $47,525 for the 1Q2021, a 58% improvement from the comparative quarter in the previous year.                                                                 ...

Continue reading

Bath & Body Works Declares Cash Dividend

COLUMBUS, Ohio, May 13, 2022 (GLOBE NEWSWIRE) — Bath & Body Works, Inc. (NYSE: BBWI) announced today the declaration of its regular quarterly dividend of $0.20 per share payable on June 17, 2022 to shareholders of record at the close of business on June 3, 2022. ABOUT BATH & BODY WORKS: Bath & Body Works is one of the world’s leading specialty retailers and home to America’s Favorite Fragrances® offering a breadth of exclusive fragrances for the body and home, including the #1 selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap. For more than 30 years, customers have looked to Bath & Body Works for quality, on-trend products and the newest, freshest fragrances. Today, these fragrant products can be purchased at more than 1,750...

Continue reading

Stelmine Completes Phase 1 Drilling at Courcy

Courcy Drill Hole Location Map Courcy Drill Hole Location MapQUEBEC CITY, May 13, 2022 (GLOBE NEWSWIRE) — Stelmine Canada (TSXV: STH) (“Stelmine” or the “Company”) is pleased to announce that the Company has completed Phase 1 drilling at its 100%-owned Courcy Project where the target is near-surface gold mineralization in a vastly under-explored part of northern Quebec with district scale potential. Highlights:A total of 14 drill holes comprising 2,237 metres were completed in Phase 1; Twelve of the 14 holes tested Zone 1. Three of those holes intersected visible gold including STH21-COU12 collared 300 metres east of SOQUEM’s 2006 discovery hole that returned 42 m grading 4.2 g/t Au; Stelmine drilling has significantly extended the prospective gold system in Zone 1 to at least 300 metres along the Couteau Fault; Multiple additional...

Continue reading

Better Choice Company Announces Insider Purchase Program of Approximately 2.5% of Common Shares Outstanding

NEW YORK, May 13, 2022 (GLOBE NEWSWIRE) — Better Choice Company Inc. (NYSE: BTTR) (the “Company” or “Better Choice”), a pet health and wellness company, announces that certain members of its Board of Directors and Management team (the “Insiders”) have informed the Company of their intention, on an individual basis and not in concert, to use their personal funds to purchase approximately 2.5% of the Company’s common shares outstanding. The Insiders may purchase approximately 750,000 common shares (the “Securities”) on the open market, representing approximately 2.5% of basic common shares outstanding within the one-month period commencing May 16, 2022. Any Insider purchase will be conducted in compliance with the Company’s insider trading policy and Insiders will meet the SEC reporting obligations. Insiders’ proposed purchases...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.